Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management. American drugmaker Eli Lilly and Company launched ...

First came lost poise. Then a lost game. The Nets squandered a double-digit cushion, and a five-point edge with seconds left in regulation Thursday. In the end, they fell to Indiana 105-99 before ...

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling with obesity and diabetes. Priced between 3,500 and 4,375 rupees per vial, ...

New Delhi: Eli Lilly has officially introduced Mounjaro (tirzepatide) in India, marking a major milestone in diabetes and weight-loss treatment. The drug, which has seen tremendous global demand ...

The weight loss medicine is sold for $1,086.37 for each fill in the United States. Whereas, Lilly offers 7.5 mg and 10 mg vials of Zepbound for $499 a month via its website. According to WebMD ...

used to make Novo’s weight loss medicine, start to expire in 2026. Locally, India’s largest pharma firm Sun Pharmaceutical Industries Ltd. is developing its own weight-loss formulation ...

A range of generic weight-loss drugs are forecast to hit the market when patents of semaglutide, used to make Novo’s weight loss medicine, start to expire in 2026. Locally, India’s largest pharma firm ...

Launched in 2022, it contains the same ingredient semaglutide as Wegovy and Ozempic, but is considered less effective than the blockbuster injectables. A range of generic weight-loss drugs are ...

Two major components of healthy, sustainable weight loss are: Eat nutrient-dense foods. Fast food, sodas, and processed foods are high in calories while being low in vitamins, minerals ...